Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers

PURPOSE: Our recent study showed a high rate of HBsAg clearance in inactive HBsAg carriers (IHCs) treated with pegylated IFN (PEG-IFN). To better understand the immune-mediated component of HBsAg clearance, this study investigated the role of serum immunoglobulin G (IgG) and its subclasses in predic...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hong, Lin, Xiao, Liu, Lili, Qin, Ling, Zheng, Yanhong, Liu, Xiaohui, Wei, Xinhuan, Liang, Shan, Liu, Yali, Zhang, Jing, Chen, Xinyue, Cao, Zhenhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073012/
https://www.ncbi.nlm.nih.gov/pubmed/35529845
http://dx.doi.org/10.3389/fimmu.2022.864354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073012/
https://www.ncbi.nlm.nih.gov/pubmed/35529845
http://dx.doi.org/10.3389/fimmu.2022.864354

Ejemplares similares